Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical CancerThe New England journal of medicine, 2021-11, Vol.385 (20), p.1856-1867 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112435 ;PMID: 34534429Full text available |
|
2 |
Material Type: Article
|
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort studyThe lancet oncology, 2021-04, Vol.22 (4), p.538-547 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30753-1 ;PMID: 33794207Full text available |
|
3 |
Material Type: Article
|
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical CancerThe New England journal of medicine, 2018-11, Vol.379 (20), p.1905-1914 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1804923 ;PMID: 30379613Full text available |
|
4 |
Material Type: Article
|
Water-dispersible PEG-curcumin/amine-functionalized covalent organic framework nanocomposites as smart carriers for in vivo drug deliveryNature communications, 2018-07, Vol.9 (1), p.2785-11, Article 2785 [Peer Reviewed Journal]2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-018-04910-5 ;PMID: 30018290Full text available |
|
5 |
Material Type: Article
|
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 studyThe lancet oncology, 2021-05, Vol.22 (5), p.609-619 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00056-5 ;PMID: 33845034Full text available |
|
6 |
Material Type: Article
|
Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic reviewThe lancet oncology, 2016-06, Vol.17 (6), p.e240-e253 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30032-8 ;PMID: 27299280 ;CODEN: LANCAOFull text available |
|
7 |
Material Type: Article
|
Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirusNature communications, 2019-05, Vol.10 (1), p.2300-12, Article 2300 [Peer Reviewed Journal]The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-10246-5 ;PMID: 31127091Full text available |
|
8 |
Material Type: Article
|
Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1Oncogene, 2019-02, Vol.38 (8), p.1256-1268 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/s41388-018-0511-x ;PMID: 30254211Full text available |
|
9 |
Material Type: Article
|
Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervixModern pathology, 2016-07, Vol.29 (7), p.753-763 [Peer Reviewed Journal]Copyright Nature Publishing Group Jul 2016 ;Copyright © 2016 United States & Canadian Academy of Pathology 2016 United States & Canadian Academy of Pathology ;ISSN: 0893-3952 ;EISSN: 1530-0285 ;DOI: 10.1038/modpathol.2016.64 ;PMID: 27056074 ;CODEN: MODPEOFull text available |
|
10 |
Material Type: Article
|
Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancerNature communications, 2022-05, Vol.13 (1), p.2563-2563, Article 2563 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-30190-1 ;PMID: 35538075Full text available |
|
11 |
Material Type: Article
|
Human papillomavirus and cervical cancerThe Lancet (British edition), 2013-09, Vol.382 (9895), p.889-899 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 7, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60022-7 ;PMID: 23618600 ;CODEN: LANCAOFull text available |
|
12 |
Material Type: Article
|
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trialThe lancet oncology, 2020-12, Vol.21 (12), p.1653-1660 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30486-1 ;PMID: 33271094Full text available |
|
13 |
Material Type: Article
|
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapyProceedings of the National Academy of Sciences - PNAS, 2019-11, Vol.116 (45), p.22730-22736 [Peer Reviewed Journal]Copyright National Academy of Sciences Nov 5, 2019 ;2019 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1911385116 ;PMID: 31624127Full text available |
|
14 |
Material Type: Article
|
The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progressionEMBO molecular medicine, 2015-11, Vol.7 (11), p.1426-1449 [Peer Reviewed Journal]2015 The Authors. Published under the terms of the CC BY 4.0 license ;2015 The Authors. Published under the terms of the CC BY 4.0 license. ;2015. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Published under the terms of the CC BY 4.0 license 2015 ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201404976 ;PMID: 26417066Full text available |
|
15 |
Material Type: Article
|
Monocarboxylate Transporter MCT1 Promotes Tumor Metastasis Independently of Its Activity as a Lactate TransporterCancer research (Chicago, Ill.), 2017-10, Vol.77 (20), p.5591-5601 [Peer Reviewed Journal]2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research, Inc. Oct 15, 2017 ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-17-0764 ;PMID: 28827372Full text available |
|
16 |
Material Type: Article
|
Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancerOncogene, 2018-09, Vol.37 (39), p.5257-5268 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/s41388-018-0347-4 ;PMID: 29855617Full text available |
|
17 |
Material Type: Article
|
Radical Hysterectomy for Early Stage Cervical CancerInternational journal of environmental research and public health, 2022-09, Vol.19 (18), p.11641 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1660-4601 ;ISSN: 1661-7827 ;EISSN: 1660-4601 ;DOI: 10.3390/ijerph191811641 ;PMID: 36141917Full text available |
|
18 |
Material Type: Article
|
Prospective Multicenter Study Evaluating the Survival of Patients With Locally Advanced Cervical Cancer Undergoing Laparoscopic Para-Aortic Lymphadenectomy Before Chemoradiotherapy in the Era of Positron Emission Tomography ImagingJournal of clinical oncology, 2013-08, Vol.31 (24), p.3026-3033 [Peer Reviewed Journal]2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.47.3520 ;PMID: 23857967Full text available |
|
19 |
Material Type: Article
|
Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironmentCell death and differentiation, 2021-02, Vol.28 (2), p.715-729 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1350-9047 ;EISSN: 1476-5403 ;DOI: 10.1038/s41418-020-00618-6 ;PMID: 32929219Full text available |
|
20 |
Material Type: Article
|
Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCRBritish journal of cancer, 2020-12, Vol.123 (12), p.1790-1795 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;ISSN: 1532-1827 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01111-0 ;PMID: 33020595Full text available |